Schering-Plough Publishes Data On Allergic Rhinitis
New data published by Schering-Plough this week in the Primary Care Respiratory Journal (PCRJ) showed that allergic rhinitis quadruples the likelihood of asthma patients having poor control over
AstraZeneca and Sino Biopharmaceutical’s subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ) have signed an exclusive licence agreement for TQC3721.